Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection
- 1 October 2007
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 20 (4), 660-694
- https://doi.org/10.1128/cmr.00023-07
Abstract
Before the emergence of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) in 2003, only 12 other animal or human coronaviruses were known. The discovery of this virus was soon followed by the discovery of the civet and bat SARS-CoV and the human coronaviruses NL63 and HKU1. Surveillance of coronaviruses in many animal species has increased the number on the list of coronaviruses to at least 36 The explosive nature of the first SARS epidemic, the high mortality, its transient reemergence a year later, and economic disruptions led to a rush on research of the epidemiological, clinical, pathological, immunological, virological, and other basic scientific aspects of the virus and the disease. This research resulted in over 4, 000 publications, only some of the most representative works of which could be reviewed in this article. The marked increase in the understanding of the virus and the disease within such a short time has allowed the development of diagnostic tests, animal models, antivirals, vaccines, and epidemiological and infection control measures, which could prove to be useful in randomized control trials if SARS should return. The findings that horseshoe bats are the natural reservoir for SARS-CoV-like virus and that civets are the amplification host highlight the importance of wildlife and biosecurity in farms and wet markets, which can serve as the source and amplification centers for emerging infections.Keywords
This publication has 427 references indexed in Scilit:
- Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivityBiochemical and Biophysical Research Communications, 2007
- A second, non-canonical RNA-dependent RNA polymerase in SARS CoronavirusThe EMBO Journal, 2006
- Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike proteinVirus Research, 2006
- Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradationProceedings of the National Academy of Sciences of the United States of America, 2006
- Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus releaseProceedings of the National Academy of Sciences of the United States of America, 2006
- Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease familyProceedings of the National Academy of Sciences of the United States of America, 2006
- Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzymeProceedings of the National Academy of Sciences of the United States of America, 2006
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- Identification of a new human coronavirusNature Medicine, 2004